Skip to main content
. 2015 Sep 16;7:401–410. doi: 10.2147/CLEP.S84279

Table 2.

Characteristics of patients with VTE events at the time of VTE diagnosis within the separate cohorts and in the merged STAC cohort

Tromsø 4 HUNT 2 DCH STAC
Subjects with VTE 664 989 791 2,444
Age at VTE diagnosis 69 (44–88) 69 (41–88) 65 (56–74) 68 (45–87)
Sex (men) 46.7 (310) 47.9 (474) 56.4 (446) 50.3 (1,230)
VTE type
 PEa 42.8 (284) 38.7 (383) 41.2 (326) 40.6 (993)
 DVTa 57.2 (380) 61.3 (606) 54.5 (431) 58.0 (1,417)
 Unprovoked VTEb 44.9 (298) 52.0 (514) 49.9 (367) 49.4 (1,179)
 Provoked VTEb 55.1 (366) 48.0 (475) 50.1 (369) 50.6 (1,210)
Provoking factorsb
 Overt cancer 22.9 (152) 15.7 (155) 19.7 (156) 18.9 (463)
 Surgery 14.3 (95) 17.1 (169) 11.4 (84) 14.6 (348)
 Trauma 7.7 (51) 10.4 (103) 0 6.4 (154)
 Acute medical condition 14.3 (95) N/A 10.2 (75) 7.1 (170)
 Immobilization 17.6 (117) 16.3 (161) 11.1 (82) 15.1 (360)
 Travel 0.9 (6) 2.5 (25) 5.7 (42) 3.1 (73)
 Other factor 5.1 (34) 5.4 (53) 5.7 (42) 4.1 (129)

Notes: Values are percentages with absolute numbers in parentheses or mean with 5–95% ranges in parentheses.

a

There are 34 subjects in the DCH Study with missing information for PE and DVT;

b

several subjects have more than one provoking factor. The given percentages of unprovoked VTE, provoked VTE, and each provoking factor are among total VTE events in each study with exclusion of 55 events with missing information on provoking factors in the DCH Study.

Abbreviations: STAC, Scandinavian Thrombosis and Cancer; DCH, Danish Diet, Cancer and Health Study; HUNT 2, second Nord-Trøndelag Health Study; VTE, venous thromboembolism; DVT, deep venous thrombosis; PE, pulmonary embolism; N/A, not applicable.